
Jeplus.in
Purchase All Medicines.Get 10% Offer

Pharma Tech
Pfizer has an extensive clinical programme for berobenatide, acquired via its $10bn takeover of Metsera.

Pharma Tech
Emerging mechanisms and combinatorial approaches are redefining the obesity space as the outcome focus shifts away from weight loss alone.

Pharma Tech
The attending members of the editorial team talk through the key themes and takeaways from the 2026 BIO-Europe conference.

Express Pharma
Breakthrough at IIT Kanpur opens a new direction in diabetes research, discovers a new path of communication between immune cells and insulin-producing cells The post IIT Kanpur scientists discover how immune cells silence insulin appeared first on Express Pharma.

Express Pharma
Indigenously developed through in-house R&D, the product marks a significant milestone in Biodealās evolution from a manufacturing-led CDMO to an innovation-driven pharmaceutical company. The post Biodeal Pharmaceuticals receives CDSCO approval for Midazolam nasal spray appeared first on Express Pharma.
Sponsored content

Purchase All Medicines.Get 10% Offer
News
Pharma Tech
Nov 12, 2026, 3:13 PM
Pfizer has an extensive clinical programme for berobenatide, acquired via its $10bn takeover of Metsera.
PharmaShots
Nov 12, 2026, 1:30 PM
Shots: The post PharmaShots Magazine-Nov-2026 Edition appeared first on PharmaShots.
Pharma Tech
Nov 12, 2026, 1:11 PM
Emerging mechanisms and combinatorial approaches are redefining the obesity space as the outcome focus shifts away from weight loss alone.
Pharma Tech
Nov 12, 2026, 11:58 AM
The attending members of the editorial team talk through the key themes and takeaways from the 2026 BIO-Europe conference.
Express Pharma
Nov 12, 2026, 11:23 AM
Breakthrough at IIT Kanpur opens a new direction in diabetes research, discovers a new path of communication between immune cells and insulin-producing cells The post IIT Kanpur scientists discover how immune cells silence insulin appeared first on Express Pharma.
PharmaShots
Nov 12, 2026, 11:00 AM
Shots: C2N Diagnostics & LSI Medience have partnered to pursue regulatory approval & commercialization of the PrecivityAD2 blood test for Alzheimerās disease in Japan, following its recent US FDA clearance Under the Japan domestic sales agreement, LSI Medience will act as distributor, seek Japanese IVD approval & support insurance coverage, while PHC Group company Mediford⦠The post C2N Diagnostics and LSI Medience Partner to Commercialize PrecivityAD2 Blood Test for Alzheimerās Disease in Japan appeared first on PharmaShots.
News
Google News
Nov 12, 2026, 10:32 PM
Insider Selling: Teva Pharmaceutical Industries (NYSE:TEVA) CEO Sells $10,560,000.00 in StockĀ Ā MarketBeat
Google News
Nov 12, 2026, 10:18 PM
Teva Pharmaceutical Industries (NYSE:TEVA) Stock: Insider Richard Daniell Sells 20,003 SharesĀ Ā MarketBeat
Google News
Nov 12, 2026, 10:18 PM
Teva Pharmaceutical Industries (NYSE:TEVA) EVP Richard Daniell Sells 25,000 Shares of StockĀ Ā MarketBeat
Google News
Nov 12, 2026, 10:07 PM
Aptar Pharma Expands Services Capabilities to Support Development of Inhaled and Nasal Drug Products Containing Controlled SubstancesĀ Ā Aptar
Google News
Nov 12, 2026, 9:50 PM
Smart Pill Dispensers Market Size, Forecasts Report 2026-2035Ā Ā Global Market Insights Inc.
Google News
Nov 12, 2026, 9:31 PM
ICIG Backs WeylChem Bilbao Sulfur-Melting Capacity StudyĀ Ā CHEManager
Google News
Nov 12, 2026, 9:01 PM
Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End ResultsĀ Ā Arrowhead Pharmaceuticals, Inc.
Google News
Nov 12, 2026, 9:00 PM
Big pharma restructurings in Korea spur union strikes amid role cutsĀ Ā Chosunbiz
Google News
Nov 12, 2026, 8:21 PM
Indian companies bet big on US manufacturing with more than $40 billion in investmentsĀ Ā The American Bazaar
Sponsored placement

Purchase All Medicines.Get 10% Offer